Navidea Biopharma (NAVB) Reports Q4 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/18/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. SPY
10. PNC

Go back to Navidea Biopharma (NAVB) Reports Q4 Results

Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results

March 23, 2022 7:30 AM EDT

Conference Call to be held Wednesday, March 23, 2022 at 5:00 pm (EST)

DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (Navidea or the Company), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the fourth quarter and year-to-date for the period ended December 31, 2021.

Alexander L. Cappello, Chair of Navideas Board of Directors, said, We remain focused on our mission of developing precision immunodiagnostic agents and immunotherapeutics to enhance patient care. We are confident that our strong management team, supported... More